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Genentech Inc., South San Francisco, CaliforniaABSTRACT Monoclonal antibodies (mAbs) are a major class of biopharmaceuticals. It is hypothesized that some concen-
trated mAb solutions exhibit formation of a solution phase consisting of reversibly self-associated aggregates (or reversible clus-
ters), which is speculated to be responsible for their distinct solution properties. Here, we report direct observation of reversible
clusters in concentrated solutions of mAbs using neutron spin echo. Specifically, a stable mAb solution is studied across a tran-
sition from dispersed monomers in dilute solution to clustered states at more concentrated conditions, where clusters of a
preferred size are observed. Once mAb clusters have formed, their size, in contrast to that observed in typical globular protein
solutions, is observed to remain nearly constant over a wide range of concentrations. Our results not only conclusively establish
a clear relationship between the undesirable high viscosity of some mAb solutions and the formation of reversible clusters with
extended open structures, but also directly observe self-assembled mAb protein clusters of preferred small finite size similar to
that in micelle formation that dominate the properties of concentrated mAb solutions.INTRODUCTIONThe development of human therapeutics based on mono-
clonal antibodies (mAbs) and related products have evolved
rapidly since the late 1980s, with an almost exponential
growth in market value (1–4). Since antibody-based drugs
have a high selectivity, few side effects, and good reproduc-
ibility, they have been applied in a broad number of clinical
settings, including cancer treatment, chronic inflammatory
diseases, transplantation, infectious diseases, and cardiovas-
cular medicine (1,2,4,5).
The importance of mAb-based drugs in treating a wide
range of diseases has motivated fundamental research into
problems related to their manufacturability and ease of clin-
ical use. One important industrial challenge is to minimize
the viscosity of highly concentrated mAb protein solutions
(2). A high viscosity can hinder large-scale production, pu-
rification, and delivery of these drugs at high concentrations.
In particular, viscosities exceeding ~50 mPa,S make it diffi-
cult to deliver drugs via subcutaneous (SC) injection (2,3).
For some mAbs, this viscosity can be easily exceeded at
the high protein concentrations (100–200 mg/mL) typically
required for SC delivery. Another situation where the vis-
cosity and diffusivity in dense environments is important
is in the concentrated regions of endogenous proteins in
intracellular environments. Thus, the understanding of the
relationship between protein concentration and viscositySubmitted December 16, 2013, and accepted for publication February 26,
2014.
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applications.
It is hypothesized that the formation of reversibly self-
associated aggregates (or reversible, nonpermanent clusters)
at relatively high protein concentrations (>100 mg/mL)
causes the high viscosities observed for some mAb solutions
(2,6–8). One important characteristic of these clusters is that
the clustering is reversible, i.e., clusters form at high con-
centrations and dissociate into monomers at sufficiently
low concentrations. However, to date, it has been difficult
to directly observe these mAb clusters and quantitatively
characterize their microstructure in crowded environments.
Therefore, the properties of mAb clusters are not clearly
understood, and the relationship between the properties of
clusters and high viscosity remains unclear. In addition to
its relevance to the biopharmaceutical industry, protein
clustering is of general interest in globular protein solutions
and is a significant topic of current debate (9–13). The char-
acterization of reversible cluster formation in mAb proteins
can also provide new information that adds to our general
physical understanding of clustering phenomena (14–19).
The novelty of our approach is that we combine the
methods of small-angle neutron/x-ray scattering (SANS/
SAXS), neutron spin echo (NSE), and computer simulations
to conclusively identify the formation of reversible clusters
and the morphology of clusters in highly concentrated and
viscous mAb solutions. In particular, NSE makes it possible
to estimate the hydrodynamic radius and characterize the
dynamic properties in concentrated solutions. Our results
provide conclusive evidence of the connection between thehttp://dx.doi.org/10.1016/j.bpj.2014.02.036
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and the undesirable high viscosity of some mAb solutions.EXPERIMENTAL DETAILS
Materials and Methods
Two full-length humanized mAbs with markedly different
solution viscosities, denoted mAb1 and mAb2, are used as
model systems. Both mAbs are constructed with the same
human IgG1 framework and thus have nearly the same
molecular mass (z150 kDa) and primary structure, with
small sequence differences confined to the complemen-
tarity-determining region. The samples are purified so that
the number of irreversible dimers is <3.2% for mAb1
and <0.5% for mAb2 (20). The structural properties of
the solutions are dominated by monomers or reversibly
associated aggregates. Detailed descriptions of these two
mAbs can be found in the literature (7,20,21).
Lyophilized forms of these mAbs are reconstituted into
D2O-based buffers to reduce the incoherent background
during neutron-scattering experiments. All of the formula-
tions in this study are in 32 mM histidine/histidine-HCl
buffer with 360 mM sucrose and 0.6 mg/mL polysorbate-
20 (P-20) at pD z6.4 in D2O. The theoretical net charges
are þ17 for mAb1 and þ27 for mAb2 (21).
All rotational shear data were acquired on a stress-rate-
controlled rheometer (Physica MCR 501, Anton Paar,
Graz, Austria) using a 50 mm 0.490 anodized aluminum
cone geometry with the temperature set at 20 5 0.1C for
all experiments. A flow sweep, ascending and descending
from 1 s1 to 2000 s1, was performed to check for hyster-
esis and sample degradation. mAb1 and mAb2 were
measured at 5, 10, 20, 50, 100, and 150 mg/mL in their
D2O buffers. All samples were stable and reversible, with
negligible hysteresis.
The SANS data were collected on the NG3 and NG7
beamlines at the NIST Center for Neutron Research
(NCNR, Gaithersburg, MD). NSE experiments were per-
formed on the NG5 at NCNR and on IN15 at Institut Laue-
Langevin (ILL, Grenoble, France). The raw data were
reduced and analyzed with the Igor Pro NCNR SANS soft-
ware according to standard methods (23). The SAXS data
were collected at the F2 beamline of the Cornell High Energy
Synchrotron Source (CHESS). (It should be noted that
reference in this document to certain commercial equipment,
instruments, or materials does not imply recommendation or
endorsement by the National Institute of Standards and
Technology, nor does it imply that the products identified
are necessarily the best available for the purpose.)Theory for SANS/SAXS and NSE
When a particle is not spherical, as is the case for many
nonglobular proteins, the measured SANS/SAXS intensity,Biophysical Journal 106(8) 1763–1770I(Q), can be estimated, using the decoupling approximation
(24,25), as
IðQÞ ¼ fVpðDrÞ2PðQÞ~SðQÞ þ B; (1)
where B is the background, Vp and f are the volume of one
individual particle and the sample volume fraction, and Dr
is the scattering-length density difference between a particle
and the solvent. Q ¼ ð4p=lÞ sin ðq=2Þ, where q is the scat-
tering angle and l is the neutron/x-ray wavelength. P(Q) is
the angular averaged form factor, and ~SðQÞ is the apparent
interparticle structure factor, which is linked to the true
interparticle structure factor, S(Q), using the decoupling
approximation (24,26):





where F(Q) is the Fourier transformation of the density dis-
tribution of an individual particle. The angled brackets indi-
cate the angular average of all possible orientations of a
particle. Note that <jF(Q)j2> is equal to P(Q).
NSEmeasures the intermediate scattering function, I(Q,t)/
I(Q), which can be fitted by a diffusion model to extract the
apparent diffusion coefficient, D(Q). The latter contains the
information of both internal dynamics and translational
motion of particles in solution. We show later that in our ex-
periments, the internal dynamics can be ignored such that the
apparent diffusion coefficient is a good approximation of the
translational diffusion coefficient.
In a colloidal system, solvent dynamics are typically very
fast relative to those of colloidal particles. The relaxation
time, tB, of a colloidal particle after it is perturbed by sol-
vent molecules is typically very small (27). When the mea-
surement time, t, is much larger than tB, colloidal particles
are observed to execute Brownian motion. When a colloidal
particle diffuses for a sufficiently long time, it will collide
with other particles and diffusion will be hindered. This
time is called the structural relaxation time, tI. Generally,
when tB  t  tI, a colloidal particle is considered to






where R0 is the radius and D0 the diffusion coefficient of the
colloidal particle at infinite dilution (27). In the short-time




IðQÞ ¼ eQ2DcðQÞt; (4)
where DcðQÞ ¼ D0ðHðQÞ=SðQÞÞis the collective diffusion
coefficient (27–29), andH(Q) is the hydrodynamic function,
Cluster Formation in Protein Solutions 1765indicating how the particle diffusion is affected by compli-
cated solvent flow patterns created by motions of the
colloidal particles themselves. In the large Q limit,
Dc(Q) ¼ Ds, where Ds is the self-diffusion coefficient at
the short-time limit. Given the size of a mAb protein,
NSE measures the short-time dynamics of mAb proteins.FIGURE 1 (a) Viscosity of mAb1 (solid circles) and mAb2 (solid
squares) samples without added salts. (b) Viscosity of mAb1 and mAb2
samples at 150 mg/mL as a function of added salt concentration in buffers.
(c and d) SANS patterns of mAbs at 150 mg/mL with (c) 0 mMNaC and (d)
150 mM NaCl. All measurements were performed at 25C. Vertical lines
indicate error bars with one standard deviation. Most error bars are smaller
than the symbols. To see this figure in color, go online.Computer simulations
Computer simulations are carried out to investigate the solu-
tion morphology of mAb dimers. We construct mAb dimers
by associating two mAbs in various configurations, calcu-
lating the radius of gyration, and then comparing these
calculations to experimental results. To survey potential
relative positions of two mAb molecules in solution, we
implemented a grid-based fast Fourier transform (FFT)
docking algorithm based on shape complementarity, which
was determined using Fourier correlation (30). A suffi-
ciently large 3-dimensional grid was built around a single
mAb molecule, and the grid spacing was set at 0.7 A˚. A
single target mAb molecule was centered and fixed on the
grid, whereas a second ligand mAb molecule experienced
stepwise Euler rotation. The radius parameter to construct
the real-space map was set to be 1.8 A˚, the surface layer
thickness was set to be 2.5 A˚, and the interior parameters
(r and d) of the target and ligand mAb molecules were set
to be 15 and 1, respectively. The relative orientation of
the ligand mAb with respect to the target mAb was sampled
at a fixed interval of 5 along each Euler angle, yielding
23,328 structures that were evaluated using the FFT
docking algorithm for surface complementarity. Sampling,
FFT docking, and small-angle scattering calculations were
carried out using SASSIE (31).RESULTS AND DISCUSSION
Fig. 1 a shows the solution viscosity (h) as a function of con-
centration, C, at 25C, for mAb1 and mAb2. Note that
mAb1 has an anomalously large viscosity of 310 mPa,S
at 150 mg/mL, as compared to many other mAbs that
have much lower viscosity at this concentration. For
example, h for mAb2 is only 18 mPa,S at 150 mg/mL
(Fig. 1 a). Even though h of mAb1 is not high compared
to that of many other soft materials, such as polymer blends
and colloidal glass/gel systems (32), it is sufficiently high to
limit the allowable concentration for bulk manufacturing, as
well as SC delivery. Interestingly, adding electrolyte (NaCl)
significantly reduces the viscosity of concentrated mAb1
solutions, whereas it has a negligible effect for mAb2
(Fig. 1 b). The viscosity dependence on concentration and
salt exhibits the same trends observed using water-based
buffer, as reported in the literature (7). Fig. 1 c further com-
pares the SANS patterns of the two mAb solutions at
150 mg/mL without added electrolyte. The scattering inten-
sity for mAb2 shows a strong correlation peak due to thestrong electrostatic repulsion between nearest neighbors.
In contrast, mAb1 solutions show significantly less structure
due to their anisotropic interaction potential, as discussed
previously (21). With the addition of 150 mM NaCl, the
electrostatic repulsion between mAb2 in solution is partly
screened, as shown by the increase in scattering intensity
at lowQ (Fig. 1 d). Similar changes in the scattering patterns
for mAb1 solutions are observed where I(Q) shows a signif-
icant increase in forward-scattering intensity when salts
are added.
To identify cluster formation, some insights can be gained
initially from examining the SAXS patterns of low-concen-
tration solutions. The SAXS results for mAb1 and mAb2 at
5 mg/mL are shown in Fig. 2 a. The coherent scattering
intensity, I(Q), can be expressed by Eq. 1. At very low con-
centrations, ~SðQÞ z 1 and the apparent radius of gyration,
RG, can be estimated by Guinier analysis, as shown in
Fig. 2 b. At 1 mg/mL, the apparent RG is the same for
both mAbs and corresponds to that of dispersed monomers
in solution. However, when C increases, the apparent RG for
mAb2 decreases slightly due to the long-range electrostatic
repulsion between the mAb2 proteins. In contrast, the
apparent RG of mAb1 increases from 5 nm at 1 mg/mL to
6.9 nm at 10 mg/mL, which is reversible upon dilution.
Unlike mAb2, which remains dispersed as a monomer up
to 10 mg/mL, a reversible clustering is apparent in mAb1 so-
lutions. The cluster formation in mAb1 is further confirmedBiophysical Journal 106(8) 1763–1770
FIGURE 2 (a) SAXS patterns at 5 mg/mL without added salts. (b and c)
The radius of gyration (b) and hydrodynamic radius (c) of both mAbs are
shown. (d) Apparent Mw of mAb1, obtained from SAXS data. Vertical lines
indicate error bars with one standard deviation. Most error bars are smaller
than the symbols. To see this figure in color, go online.
1766 Yearley et al.by dynamic-light-scattering (DLS) measurements of the
collective diffusion coefficient, Dc(Q). Using DLS, an
approximate hydrodynamic radius, RH, can be estimated
from the Stokes-Einstein-Sutherland equation, as shown in
Fig. 2 c (29). (Although the structure factor, S(Q), can affect
the estimated hydrodynamic radius, the estimated error from
S(Q) is minor and does not affect our conclusions.) The
apparent RH for mAb2 remains constant at z5.4 nm when
C % 10 mg/mL, whereas the RH for mAb1 is the same as
that of mAb2 at 1 mg/mL and increases to 8.5 nm at
10 mg/mL. Again, it should be noted that this microstructure
formation in mAb1 solutions is fully reversible upon dilu-
tion. Hence, the microstructure in mAb1 solutions consists
of reversible clusters in equilibrium with monomers.
The average apparent molecular mass, Mw, of the mAb1
clusters is further estimated using I(Q ¼ 0). Assuming that
~SðQ ¼ 0Þz1, I(0)z ðCVpDr2=r2mNAÞMw, where rm is the
mass density of an mAb protein, Mw is the average molec-
ular mass of monomer or clusters in solutions, and NA is the
Avogadro constant. The prefactor for Mw is independent of
mAb protein structure at a given concentration and as such
can be calculated using the scattering intensity and known
Mw (z150 kDa) of mAb2. Using the estimated prefactor
value based on mAb2, the Mw of reversible clusters of
mAb1 is estimated as a function of concentration
(Fig. 2 d). It approachesz250 kDa at 10 mg/mL, consistent
with previous static-light-scattering measurements at low
concentrations (34). Note that ignoring ~SðQÞmay underesti-Biophysical Journal 106(8) 1763–1770mate Mw by z20% at 10 mg/mL. (See the Supporting
Material for details.) Therefore, the average molecular
mass of formed clusters of mAb1 is close to that of an
mAb dimer (Mw z 300 kDa). Hence, the microstructure
of mAb1 in solution progresses from dispersed monomers
to an increasing proportion of clusters as the concentration
increases from 1 to 10 mg/mL. The formation of clusters
at low concentrations (<10 mg/mL) in mAb1 suggests
that cluster size needs to be determined at higher concentra-
tions, where the solutions exhibit an anomalously large
viscosity (Fig. 1 a).
To extract a quantitatively accurate cluster size in the
highly concentrated protein solution region, we use NSE
to measure the short-time self-diffusion coefficient, Ds,
of protein and to determine the hydrodynamic radius of
the diffusing species. From I(Q,t)/I(Q), we can extract
the apparent collective diffusion coefficient, Dc(Q), whose
asymptotic value at the high Q limit is the short-time self-
diffusion coefficient, Ds. The details of this method
and analysis can be found in the literature (11–
13,27,28,35–37). The Dc(Q) (Fig. 3 a) is extracted by
fitting the data with a single exponential function for the
correlation time of <50 ns. (One sample fitting of I(Q,t)/
I(Q) is shown in the Supporting Material.) Using the
method reported in the literature, we can estimate Ds by
averaging values at Q > 0.15 A˚1 (11). Note that within
our Q range and time window, the contribution of any
possible internal dynamics and rotational motions to the
apparent diffusion coefficient is negligible. Dc(Q) in
Fig. 3, a and b, remains almost constant at relatively large
Q values (Q > 0.1 A˚1). However, if internal and rota-
tional dynamics are dominant contributions, they should
produce a large increase in apparent Dc(Q) at the Q range
whose corresponding length scale is commensurate with
rotational and internal motions (38). Even for proteins
with known strong internal motions studied by NSE, where
Dc(Q) shows enhanced dynamics at large Q values, the
relaxation time at high Q is dominated by translational
motions, as the internal motions in those studies only
contribute a small portion of the apparent Dc(Q) (39,40).
Hence, the large difference we observe in Dc(Q) between
mAb1 and mAb2 is mainly due to the change of transla-
tional motions.
Clearly, Ds for mAb1 is much smaller than that for mAb2
at the same concentration, indicating that mAb1 still forms
clusters at high concentrations. The normalized self-
diffusion coefficients, Ds/D0, of mAb1 (solid circles) and
mAb2 (open circles) without added electrolyte are shown
as a function of C in Fig. 3 c. At very low concentrations,
Ds/D0 ¼ 1, as Ds is equal to the free diffusion coefficient
of a monomer, D0. The mAb2 proteins remain monomeric
in solution up to ~50 mg/mL. as Ds/D0z 1. This is consis-
tent with previous simulations and experimental results indi-
cating that mAb2 remains dispersed as monomers up to at
least 150 mg/mL without added salts (8,21,34). The
FIGURE 3 (a)Dc(Q) of mAb1 at 64 and 150 mg/mL (black solid squares
and circles, respectively) and of mAb2 at 50 and 150 mg/mL (red open
squares and circles, respectively) without added electrolyte. (b) Dc(Q) at
50 and 150 mg/mL with 150 mM NaCl added to the buffer. Solid and
open symbols are for mAb1 and mAb2, respectively. (c and d) Ds/D0 values
for mAb1 (black solid circles) and mAb2 (red open circles) without (c) and
with (d) added electrolyte. (e and f) Ratio of the 1/Ds of mAb1 to that of
mAb2 for samples without (e) and with (f) 150 mM NaCl. Vertical lines
indicate error bars with one standard deviation. Most error bars are smaller
than the symbols. To see this figure in color, go online.
Cluster Formation in Protein Solutions 1767decrease of Ds/D0 is due to the hydrodynamic interaction
effects with further increases in concentration (11,28).
Because RHf 1/Ds, the ratio of 1/Ds for mAb1 to that for
mAb2 is an estimate of the average size of the diffusing ob-
jects in mAb1 solutions relative to the corresponding value
in mAb2. (The hydrodynamic effect may slightly change the
estimated RH, but the effect is expected to be small, since
hydrodynamic function at large Q limit is not very sensitive
to interactions between colloidal particles if there is no clus-
ter formation.) As mAb2 retains its monomer structure
within our studied concentration range, this ratio can be
viewed as approximately the relative size of reversible clus-
ters in mAb1 solutions. Fig. 3 e shows the ratio of 1/Ds for
mAb1 to that for mAb2 as a function of C. Note that when
C% 10 mg/mL (Fig. 3 e, solid diamonds), Ds is obtained by
DLS, whereas at higher concentrations, Ds is obtained from
NSE. The diffusivity results confirm that at %1 mg/mL,both mAb1 and mAb2 disperse predominantly as monomers
in solution. However, by 10 mg/mL, the ratio of 1/Ds for
mAb1 to that for mAb2 reaches ~1.6. It is striking to observe
that this ratio does not change substantially with further in-
creases in concentration up to 150 mg/mL. This suggests
that once mAb1 protein clusters form at relatively low con-
centrations (z10 mg/mL), their average size remains rela-
tively constant up to relatively large concentrations. This
behavior is akin to that of self-assembled micellization in
surfactant solutions, where above a critical micelle concen-
tration all additional surfactants added to the system form
micelles. The NSE diffusivity results therefore suggest
that the critical monomer concentration for mAb1
is ~10 mg/mL. Hence, at high concentrations, such as
150 mg/mL, the dominating fraction of mAb1 species is
small reversible clusters with a preferred size.
The presence of these reversible clusters correlates with a
high solution viscosity, which indicates that controlling the
formation of clusters should adjust the viscosity of the sys-
tem accordingly. Fig. 3 b shows the Dc(Q) of mAb1 and
mAb2 solutions at 50 and 150 mg/mL with 150 mM NaCl
added. The SANS patterns at 150 mg/mL with 150 mM
NaCl are shown in Fig. 1 e. Because the electrostatic repul-
sion is screened by added salt, SANS patterns of both
proteins show a strong low-Q intensity that could be mis-
takenly interpreted as an increase in cluster size.
Conversely, Fig. 3 d clearly indicates that for mAb1 (black
solid circles), Ds/D0 increases when electrolyte is added,
signifying that the average size of the reversible clusters be-
comes smaller. The decrease in average cluster size is due to
the decrease in mAb1 protein-protein attraction. Our previ-
ous SANS study indicated that the attraction between mAb1
proteins is anisotropic and is due to the nonuniform charge
distribution on mAb protein surfaces, which can subse-
quently be screened by increasing salt concentration (21).
This decrease in average cluster size is associated with a
commensurate decrease in solution viscosity for mAb1
(Fig. 1 b); for example, the viscosity of mAb1 at
150 mg/mL is reduced by 80% upon salt addition. This pro-
vides strong evidence that the presence of small reversible
clusters is responsible for the increased viscosity of mAb1
solutions before salts are added.
The viscosity of mAb1 (Fig. 1 b, black solid circles) is
still quantitatively larger than that of mAb2 (Fig. 1 b, red
solid squares) despite the large decrease in the viscosity
of mAb1 after addition of 150 mM NaCl. To understand
the physical basis for the difference, we further compared
the Ds/D0 for mAb1 and mAb2 solutions with added salts
(Fig. 3 d, black solid circles and red open circles, respec-
tively). We found that after adding 150 mM NaCl, the
Ds/D0 becomes nearly identical for mAb1 and mAb2 at
150 mg/mL, indicating that the average size of the moving
units becomes almost equal if we assume that the hydrody-
namic interactions are similar. However, the structure
formed in mAb1 solution has a larger length scale comparedBiophysical Journal 106(8) 1763–1770
1768 Yearley et al.to that formed in the corresponding mAb2 solution, as indi-
cated by the larger low-Q SANS intensity in the mAb1
pattern (Fig. 1 d). This difference in scattering and, corre-
spondingly, in viscosity, is due to the small difference
between mAb1 interactions and mAb2 interactions in solu-
tion. Although the attraction between mAb1 proteins is
much weaker with added salts in solution, it is still slightly
stronger than that between mAb2 proteins, as also observed
previously at similar ionic strength (34). Thus, the formation
of a large-length-scale network of loosely interacting mono-
mers in mAb1 results in the slightly higher viscosity for this
solution compared to similar solutions of mAb2. In the
absence of added electrolyte, no mAb1 network will form,
as can be seen from the suppressed intensity of SANS pat-
terns in Fig. 1 c. Therefore, the dominant reason for the
increased viscosity of mAb1 solution without added salts
is mainly due to the formation of small protein clusters.
The size of reversible clusters in concentrated mAb1 so-
lutions without added salts is similar to that at 10 mg/mL, at
which concentration the apparent Mw of mAb1 clusters is
approximately that of a dimer. Hence, it is likely that dimers
dominate the solution at 10 mg/mL. It is thus useful to
consider computer models of mAb1 dimeric clusters as
the probable moving units. Dimers consisting of two iden-
tical mAbs using the crystal structure were generated by
randomly associating two proteins. Although in general
the solution structure of a mAb protein may differ from its
crystal structure, we find that the RG of the crystal structure
(~52 A˚) agrees well with the RG of the monomer protein inBiophysical Journal 106(8) 1763–1770solution, obtained by SAXS measurements at 1 mg/mL.
Therefore, we feel that the estimated RG of dimers con-
structed using the crystal structure should be very helpful
in qualitatively identifying the dimer structure. The RG
values for randomly associated dimers are shown in
Fig. 4. (Note that we did not show individual results for
all 23,328 configurations in Fig. 4, but the selected points
are representative of all configurations.) As shown in
Fig. 2 b, the mAb1 clusters have an experimental RG
ofz6.9 nm at 10 mg/mL. Only a few of the representative
configurations shown in Fig. 4 have an RG around 7.0 nm.
These configurations have an extended structure. Hence, it
is likely that the clusters at high concentration also maintain
an extended, open structure. This larger effective volume of
open-structured clusters is consistent with an increase in
solution viscosity. In contrast, the opposite effect has been
reported for a densely packed cluster (42). Such relatively
extended configurations (e.g., with Fab-Fab and Fab-Fc in-
teractions) are also seen in molecular dynamics simulations
of concentrated mAb1 solutions that use a coarse-grained
charge distribution to approximate mAb1 charge heteroge-
neity (8). The simulations also suggest that Fab-Fab interac-
tions are much more prevalent in mAb1 than in mAb2.
It is also important to note that cluster formation in mAb1
solutions is qualitatively different from that observed in
globular protein solutions such as lysozyme, where clusters
only form at relatively high concentrations (>100 mg/mL)
and the average size increases with the increase in volume
fraction (11,13). Cluster formation in mAb1 solutions firstFIGURE 4 Estimates of the RG values of dimers
in different configurations. The representative
dimers A–C correspond to the configurations indi-
cated in the plot at upper left. To see this figure in
color, go online.
Cluster Formation in Protein Solutions 1769appears at much lower concentrations (<10 mg/mL), and
the size of clusters does not change over a wide concentra-
tion range. In other words, the mAb1 proteins form clusters
with a preferred size over a relatively broad range of con-
centrations, which is a solution behavior similar to that
observed in simple micellization (43). Here, we attribute
this behavior to the very site-specific, anisotropic attraction
between mAb1 proteins observed previously using SANS
(21) and molecular modeling (8). Thus, in contrast to
models for homogeneous spherical colloids, where cluster
formation is a consequence of short-range attraction and
long-range repulsion (17), the formation of protein clusters
in our mAb solutions is driven by very specific, anisotropic
interactions between mAbs in solution. The SANS and DLS
experimental results (21,44), together with the coarse-
grained computer simulation (8), support the idea that this
specific interaction is due to the electric dipole effect, whose
interaction strength is very sensitive to the ionic strength.
This is also consistent with the observed decrease in the
average size of clusters when salt is added to solutions, as
the added salts can weaken the dipole attraction.CONCLUSION
In conclusion, using NSE and SANS/SAXS to measure
diffusivity and probe the microstructure of two model
mAb proteins in solution over a broad concentration range
with and without salt, we conclusively demonstrate that
the formation of a reversible cluster phase for mAb1 in
solution is consistent with the observed increase in viscosity
of mAb solutions. We attribute this to the increased effective
volume of clusters, as they have more extended structure.
Interestingly, the average cluster size for mAb1 is that of a
dimer, and it remains nearly identical over a wide range of
concentrations. This unique mAb solution behavior has
similarities to classical, idealized micelle formation. This
suggests a unique method for control of protein clusters
and solution viscosity by controlling these specific, aniso-
tropic interactions through engineering the primary struc-
ture of mAbs. Not only do the insights obtained here
regarding mAb clustering have important implications for
the development of mAbs and their formulations with
desired solution properties, but they also have a significant
impact on our fundamental understanding of protein clus-
tering observed in a wide range of solutions.SUPPORTING MATERIAL
Two figures and estimation of the systematical erros of the molecular mass
of mAb clusters at low concentration and a typical fitting of NSE data
are available at http://www.biophysj.org/biophysj/supplemental/S0006-
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